PATENT CLAIM ANALYSIS

Application Number: 15766881
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "262100"]

Abstract:
A composition comprising about 10 mg or less of dipyridamole formulated for oral administration and a physiologically acceptable carrier.

Claim (Index 19):
A method according to  claim 18 , wherein the sleep disorder is insomnia.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15939953', '14114669', '12845600', '12358454', '13623105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7156385671062008
- 35 USC 102 Novelty (BERT): 0.5004704114362062
- Combined Prediction Score: 0.6941217515392013
- Mean Citation Score: 156.83108
- Max Citation Score: 159.77937
- Similarity Product: 99.40971655472876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test